Scarica l'app Stockscreener
16.73
1.47%
-0.2504
Precedente Chiudi:
$16.98
Aprire:
$17.08
Volume 24 ore:
112.04K
Relative Volume:
0.20
Capitalizzazione di mercato:
$1.01B
Reddito:
$1.23M
Utile/perdita netta:
$-214.90M
Rapporto P/E:
-4.0584
EPS:
-4.1222
Flusso di cassa netto:
$-151.25M
1 W Prestazione:
+1.46%
1M Prestazione:
+9.92%
6M Prestazione:
-23.61%
1 anno Prestazione:
-44.12%
Intervallo 1D:
$16.43
$17.20
Intervallo di 1 settimana:
$16.43
$18.30
Portata 52W:
$10.91
$40.26
Spyre Therapeutics Inc Stock (SYRE) Company Profile
Nome
Spyre Therapeutics Inc
Settore
Industria
Telefono
(617) 651-5940
Indirizzo
221 CRESCENT STREET, WALTHAM
Confronta SYRE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SYRE
Spyre Therapeutics Inc
|
16.71 | 1.07B | 1.23M | -214.90M | -151.25M | -4.1222 |
|
VRTX
Vertex Pharmaceuticals Inc
|
466.86 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.28 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.55 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
596.13 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
306.88 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Spyre Therapeutics Inc Stock (SYRE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-08 | Iniziato | Leerink Partners | Outperform |
| 2025-03-18 | Iniziato | Wolfe Research | Outperform |
| 2024-09-04 | Iniziato | Wedbush | Outperform |
| 2024-07-16 | Iniziato | Evercore ISI | Outperform |
| 2024-05-02 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-01 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-12-20 | Iniziato | BTIG Research | Buy |
| 2023-12-11 | Iniziato | Guggenheim | Buy |
| 2023-12-11 | Iniziato | Jefferies | Buy |
| 2020-05-04 | Iniziato | Piper Sandler | Overweight |
| 2019-03-21 | Iniziato | JP Morgan | Overweight |
| 2018-09-04 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2018-04-24 | Iniziato | Evercore ISI | Outperform |
| 2018-03-14 | Reiterato | Needham | Buy |
Mostra tutto
Spyre Therapeutics Inc Borsa (SYRE) Ultime notizie
Visual trend scoring systems applied to Spyre Therapeutics Inc.Trade Alert System with Volume Analysis - Newser
Moving Average Trends for Spyre Therapeutics Inc. Stock: What They IndicateFree AI Screening for Swing Trade Picks - Newser
Why Spyre Therapeutics Inc. stock attracts strong analyst attentionProven Trading System with Consistent Gains - Newser
What are the technical indicators suggesting about Spyre Therapeutics Inc.Post Market Opportunities For Consistent Profits - jammulinksnews.com
Published on: 2025-07-28 18:29:12 - metal.it
Market reaction to Spyre Therapeutics Inc.’s recent newsConservative Asset Allocation Risk Analysis - Newser
Identifying reversal signals in Spyre Therapeutics Inc.RSI and MACD Signal Summary with Trends - Newser
Victory Capital Management Inc. Sells 16,230 Shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE) - Defense World
How Resilient Is Spyre Therapeutics Inc. Stock During Economic Downturns AI Trading Forecast Based on Big Data - Newser
Market reaction to Spyre Therapeutics Inc.’s recent news Free Quick Gain Stock Watch With Indicators - metal.it
How to track smart money flows in Spyre Therapeutics Inc. Free Low Volatility Stable Growth Picks - Newser
What makes Spyre Therapeutics Inc. stock price move sharplyGet real-time alerts on top stocks - jammulinksnews.com
How volatile is Spyre Therapeutics Inc. stock compared to the marketExplosive trading growth - jammulinksnews.com
How does Spyre Therapeutics Inc. compare to its industry peersInvest confidently with advanced analysis tools - jammulinksnews.com
How Resilient Is Spyre Therapeutics Inc. Stock During Economic DownturnsFree Exclusive Investment Tips - Newser
Will Spyre Therapeutics Inc. stock benefit from AI tech trendsTriple-digit returns - jammulinksnews.com
Is Spyre Therapeutics Inc. a good long term investmentHigh-impact stock picks - PrintWeekIndia
Spyre Therapeutics Inc. Stock Analysis and ForecastFree Investment Risk Control - PrintWeekIndia
What analysts say about Spyre Therapeutics Inc. stockOutstanding capital growth - Autocar Professional
This Spyre Therapeutics Insider Reduced Their Stake By 55% - 富途牛牛
What drives Spyre Therapeutics Inc. stock priceRapid capital growth - jammulinksnews.com
Brokerages Set Spyre Therapeutics, Inc. (NASDAQ:SYRE) Target Price at $53.40 - Defense World
How Spyre Therapeutics Inc. stock performs during market volatilityPredictable High Return Trades - Newser
Here's Why We're Not Too Worried About Spyre Therapeutics' (NASDAQ:SYRE) Cash Burn Situation - Yahoo Finance
Spyre Therapeutics Inc Azioni (SYRE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
9.66%
1.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):